SCHEMBL6380285

SCHEMBL6380285

O=C(Cc1ccc(OCCn2ccc3ccccc32)cc1)ONC(=O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.50
PPARG P37231 1/20 0.50
SMN1; SMN2 Q16637 4/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
MEN1 O00255 1/20 0.48
ALDH1A1 P00352 1/20 0.48
KMT2A Q03164 1/20 0.48
MAPK1 P28482 1/20 0.47
HSD17B10 Q99714 2/20 0.47
TRPV1 Q8NER1 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45
TP53 P04637 1/20 0.44
HTT P42858 1/20 0.44
MAPT P10636 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6379227 0.84 FFAR1 (0.56) FFAR1PPARGSMN1; SMN2NPC1RAB9A
SCHEMBL6380447 0.84 FFAR1 (0.56) FFAR1PPARGSMN1; SMN2NPC1RAB9A
SCHEMBL6380281 0.76 SMN1; SMN2 (0.49) FFAR1PPARGSMN1; SMN2NPC1RAB9A
SCHEMBL6380636 0.76 SMN1; SMN2 (0.49) FFAR1PPARGSMN1; SMN2NPC1RAB9A
SCHEMBL6380456 0.76 PPARG (0.57) FFAR1PPARGSMN1; SMN2NPC1RAB9A
SCHEMBL6380266 0.75 PPARG (0.54) FFAR1PPARGSMN1; SMN2NPC1RAB9A
SCHEMBL6379239 0.74 SMN1; SMN2 (0.60) FFAR1PPARGSMN1; SMN2NPC1RAB9A
SCHEMBL6536655 0.74 PPARG (0.55) FFAR1PPARGSMN1; SMN2NPC1RAB9A
SCHEMBL6380437 0.74 PPARG (0.53) FFAR1PPARGSMN1; SMN2NPC1RAB9A
SCHEMBL27468751 0.73 KMT2A (0.59) NPC1RAB9AMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050032787-A1 Pheny (alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity SIGMA-TAU INDUSTRIES FARMACEUTICHE RIUNITE S.P.A. (IT) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032787-A1 Pheny (alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity LIPC, CPT1A, GPR119 FFAR1 63/4885PPARG 127/4885SMN1; SMN2 4124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.